|
DE69826695T2
(de)
*
|
1997-05-23 |
2006-02-02 |
Bayer Pharmaceuticals Corp., West Haven |
Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
|
|
EP1473292A1
(en)
*
|
1997-11-03 |
2004-11-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
DK1047418T3
(da)
*
|
1997-12-22 |
2005-11-21 |
Bayer Pharmaceuticals Corp |
Inhibering af raf-kinase ved hjælp af substituerede heterocykliske urinstoffer
|
|
AU2006201959B2
(en)
*
|
1997-12-22 |
2008-09-04 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
ATE538794T1
(de)
*
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
US20020065296A1
(en)
*
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
EP1140840B1
(en)
*
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
RU2319693C9
(ru)
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
|
DK1690853T3
(da)
*
|
1999-01-13 |
2010-06-07 |
Bayer Healthcare Llc |
Omega-carboxyaryl-substituerede diphenylurinstoffer til anvendelse som raf-kinaseinhibitorer
|
|
UA73492C2
(en)
*
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
WO2000050425A1
(en)
|
1999-02-22 |
2000-08-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
|
ID30176A
(id)
|
1999-03-12 |
2001-11-08 |
Boehringer Ingelheim Pharma |
Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
|
|
EP1163236B1
(en)
*
|
1999-03-12 |
2005-11-09 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
EP1200411B1
(en)
|
1999-07-09 |
2005-12-14 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Process for synthesis of heteroaryl-substituted urea compounds
|
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
|
HUP0203542A3
(en)
|
1999-08-12 |
2003-07-28 |
Upjohn Co |
3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
|
|
CA2389360C
(en)
|
1999-11-16 |
2008-06-03 |
Steffen Breitfelder |
Urea derivatives as anti-inflammatory agents
|
|
SE9904177D0
(sv)
*
|
1999-11-18 |
1999-11-18 |
Astra Ab |
Novel compounds
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
GB0010757D0
(en)
|
2000-05-05 |
2000-06-28 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0016787D0
(en)
|
2000-07-07 |
2000-08-30 |
Pfizer Ltd |
Compounds useful in therapy
|
|
FR2812633A1
(fr)
*
|
2000-08-04 |
2002-02-08 |
Aventis Cropscience Sa |
Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
FR2815030A1
(fr)
*
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
EP1506962B1
(en)
|
2000-10-20 |
2008-07-02 |
Eisai R&D Management Co., Ltd. |
Nitrogen-containing aromatic heterocycles
|
|
JP2004517080A
(ja)
|
2000-11-29 |
2004-06-10 |
グラクソ グループ リミテッド |
Ｔｉｅ−２および／またはｖｅｇｆｒ−２の阻害剤として有用なベンゾイミダゾール誘導体
|
|
AU2002234056B2
(en)
*
|
2000-12-21 |
2005-04-07 |
Schering Corporation |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
|
|
US6946476B2
(en)
|
2000-12-21 |
2005-09-20 |
Schering Corporation |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
EP1382604B1
(en)
*
|
2001-04-27 |
2005-12-28 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivative having azolyl group and quinazoline derivative
|
|
JP2004530690A
(ja)
|
2001-05-16 |
2004-10-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症性薬剤として有用なジアリールウレア誘導体
|
|
WO2002096876A1
(en)
|
2001-05-25 |
2002-12-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
ATE338035T1
(de)
|
2001-06-05 |
2006-09-15 |
Boehringer Ingelheim Pharma |
1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
|
|
ATE360417T1
(de)
|
2001-07-11 |
2007-05-15 |
Boehringer Ingelheim Pharma |
Methode zur behandlung von zytokinvermittelten erkrankungen
|
|
JP4825375B2
(ja)
*
|
2001-08-28 |
2011-11-30 |
株式会社 資生堂 |
ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤
|
|
GB0121941D0
(en)
|
2001-09-11 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
PL368347A1
(en)
|
2001-09-26 |
2005-03-21 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
|
US6825184B2
(en)
|
2001-10-18 |
2004-11-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-Disubstituted benzo-fused urea compounds
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
US10653684B2
(en)
|
2002-02-11 |
2020-05-19 |
Bayer Healthcare Llc |
Aryl ureas with angiogenisis inhibiting activity
|
|
SI1580188T1
(sl)
|
2002-02-11 |
2012-02-29 |
Bayer Healthcare Llc |
Aril sečnine kot kinazni inhibitorji
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
WO2003072569A1
(en)
|
2002-02-25 |
2003-09-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
WO2003097610A1
(en)
*
|
2002-05-17 |
2003-11-27 |
Pharmacia Italia S.P.A. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
RU2340605C2
(ru)
|
2002-06-27 |
2008-12-10 |
Ново Нордиск А/С |
Арилкарбонильные производные в качестве терапевтических средств
|
|
EP1531815B1
(en)
|
2002-06-27 |
2014-09-24 |
Novo Nordisk A/S |
Glucokinase activators
|
|
ATE349210T1
(de)
|
2002-07-09 |
2007-01-15 |
Boehringer Ingelheim Pharma |
Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
|
|
DE60328202D1
(de)
*
|
2002-09-05 |
2009-08-13 |
Neurosearch As |
Diarylharnstoffderivate und deren verwendung als chloridkanalblocker
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
WO2004064730A2
(en)
*
|
2003-01-14 |
2004-08-05 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
EP1603879A2
(en)
*
|
2003-02-28 |
2005-12-14 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
|
EP1608639A2
(en)
|
2003-02-28 |
2005-12-28 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
|
BRPI0408815A
(pt)
*
|
2003-03-28 |
2006-04-04 |
Pharmacia & Upjohn Co Llc |
moduladores alostéricos positivos do receptor nicotìnico da acetilcolina
|
|
EP1626714B1
(en)
|
2003-05-20 |
2007-07-04 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas for diseases mediated by pdgfr
|
|
EP1663978B1
(en)
|
2003-07-23 |
2007-11-28 |
Bayer Pharmaceuticals Corporation |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
JP4303726B2
(ja)
|
2003-11-11 |
2009-07-29 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ウレア誘導体およびその製造方法
|
|
EP1684762A4
(en)
*
|
2003-11-13 |
2009-06-17 |
Ambit Biosciences Corp |
UREA DERIVATIVES AS MODULATORS OF KINASE
|
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
|
DK1723128T3
(da)
|
2004-01-06 |
2013-02-18 |
Novo Nordisk As |
Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
|
|
BRPI0507198A
(pt)
*
|
2004-01-30 |
2007-06-26 |
Merck Patent Gmbh |
derivados de bisariluréia
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
US20060211752A1
(en)
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
WO2005110994A2
(en)
|
2004-04-30 |
2005-11-24 |
Bayer Pharmaceuticals Corporation |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
|
AU2005264988B2
(en)
|
2004-06-17 |
2011-09-22 |
Cytokinetics, Inc. |
Substituted urea derivatives for treating cardiac diseases
|
|
EP1609789A1
(en)
*
|
2004-06-23 |
2005-12-28 |
Eli Lilly And Company |
Ureido-pyrazole derivatives and their use as kinase inhibitors
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
|
US7612200B2
(en)
|
2004-12-07 |
2009-11-03 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
US7741479B2
(en)
|
2004-12-07 |
2010-06-22 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of MAP kinases
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
CA2601955C
(en)
|
2005-03-07 |
2012-07-10 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
|
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
WO2007015578A1
(ja)
|
2005-08-02 |
2007-02-08 |
Eisai R & D Management Co., Ltd. |
血管新生阻害物質の効果を検定する方法
|
|
US7538223B2
(en)
|
2005-08-04 |
2009-05-26 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
DE102005037499A1
(de)
*
|
2005-08-09 |
2007-02-15 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
KR101400905B1
(ko)
|
2005-11-11 |
2014-05-29 |
아에테르나 젠타리스 게엠베하 |
신규한 피리도피라진 및 키나제의 조절제로서의 이의 용도
|
|
EP1790342A1
(de)
|
2005-11-11 |
2007-05-30 |
Zentaris GmbH |
Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
|
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
|
US7825120B2
(en)
|
2005-12-15 |
2010-11-02 |
Cytokinetics, Inc. |
Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
|
|
EP1959960B1
(en)
|
2005-12-15 |
2013-04-10 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
EP1959962A2
(en)
|
2005-12-16 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
US7989455B2
(en)
|
2005-12-19 |
2011-08-02 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
EP1973897B1
(en)
*
|
2005-12-21 |
2014-05-21 |
Bayer Intellectual Property GmbH |
Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
|
|
WO2007076460A2
(en)
*
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Substituted thiazole ureas useful as inhibitors of protein kinases
|
|
CA2652442C
(en)
|
2006-05-18 |
2014-12-09 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
|
WO2007139930A2
(en)
|
2006-05-26 |
2007-12-06 |
Bayer Healthcare Llc |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
|
DE102006029795A1
(de)
*
|
2006-06-27 |
2008-01-03 |
Schebo Biotech Ag |
Neue Harnstoff-Derivate und deren Verwendungen
|
|
EP2065372B1
(en)
|
2006-08-28 |
2012-11-28 |
Eisai R&D Management Co., Ltd. |
Antitumor agent for undifferentiated gastric cancer
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
WO2008079972A2
(en)
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
|
|
US8962655B2
(en)
|
2007-01-29 |
2015-02-24 |
Eisai R&D Management Co., Ltd. |
Composition for treatment of undifferentiated gastric cancer
|
|
CN101636397B
(zh)
*
|
2007-04-13 |
2012-06-13 |
中国人民解放军军事医学科学院毒物药物研究所 |
脲类化合物、其制备方法及其医药用途
|
|
BRPI0807717A2
(pt)
|
2007-04-20 |
2014-05-20 |
Deciphera Pharmaceuticals Llc |
Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
CN101848895B
(zh)
|
2007-11-09 |
2013-10-23 |
卫材R&D管理有限公司 |
血管新生抑制物质和抗肿瘤性铂络合物的组合使用
|
|
GB0818033D0
(en)
|
2008-10-02 |
2008-11-05 |
Respivert Ltd |
Novel compound
|
|
PE20110598A1
(es)
|
2008-10-02 |
2011-08-31 |
Respivert Ltd |
Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
|
|
MX2011006220A
(es)
|
2008-12-11 |
2011-06-28 |
Respivert Ltd |
Inhibidores de la proteina cinasa activada por el mitogeno p38.
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
EP2467137A1
(en)
*
|
2009-08-19 |
2012-06-27 |
Ambit Biosciences Corporation |
Biaryl compounds and methods of use thereof
|
|
ES2573515T3
(es)
|
2010-06-25 |
2016-06-08 |
Eisai R&D Management Co., Ltd. |
Agente antitumoral que emplea compuestos con efecto inhibitorio de cinasas combinados
|
|
CA2805874A1
(en)
|
2010-07-19 |
2012-01-26 |
Bayer Healthcare Llc |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
EP2508184A1
(en)
|
2011-04-06 |
2012-10-10 |
Æterna Zentaris GmbH |
Pyridopyrazine derivatives and their use
|
|
MX2013009931A
(es)
|
2011-04-18 |
2013-10-01 |
Eisai R&D Man Co Ltd |
Agentes terapeuticos contra tumores.
|
|
EP2714937B1
(en)
|
2011-06-03 |
2018-11-14 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
|
|
CN103172648B
(zh)
*
|
2011-12-20 |
2016-05-25 |
上海迪诺医药科技有限公司 |
三杂环衍生物、制备方法及应用
|
|
JP6218229B2
(ja)
|
2011-12-28 |
2017-10-25 |
京都府公立大学法人 |
角膜内皮細胞の培養正常化
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
WO2014033447A2
(en)
*
|
2012-08-29 |
2014-03-06 |
Respivert Limited |
Kinase inhibitors
|
|
HRP20161613T1
(hr)
|
2012-11-13 |
2017-01-13 |
Array Biopharma, Inc. |
Tvari bicikličke ureje, tioureje, gvanidina i cijanogvanidina korisne za liječenje boli
|
|
EP2922844B1
(en)
|
2012-11-13 |
2018-01-10 |
Array Biopharma, Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
MX2015004979A
(es)
|
2012-12-21 |
2015-07-17 |
Eisai R&D Man Co Ltd |
Forma amorfa de derivado de quinolina y metodo para su produccion.
|
|
EP2960234B1
(en)
|
2013-02-19 |
2018-12-19 |
ONO Pharmaceutical Co., Ltd. |
Trk-inhibiting compound
|
|
NZ714049A
(en)
|
2013-05-14 |
2020-05-29 |
Eisai R&D Man Co Ltd |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
|
US9750723B2
(en)
|
2013-10-31 |
2017-09-05 |
Ohio University |
Prevention and treatment of non-alcoholic fatty liver disease
|
|
EP3069732B1
(en)
|
2013-11-14 |
2023-07-12 |
The Doshisha |
Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
|
|
RU2719489C2
(ru)
|
2014-05-15 |
2020-04-17 |
Эррэй Биофарма Инк. |
1-((3S,4R)-4-(3-ФТОРФЕНИЛ)-1-(2-МЕТОКСИЭТИЛ)ПИРРОЛИДИН-3-ИЛ)-3-(4-МЕТИЛ-3-(2-МЕТИЛПИРИМИДИН-5-ИЛ)-1-ФЕНИЛ-1Н-ПИРАЗОЛ-5-ИЛ)МОЧЕВИНА В КАЧЕСТВЕ ИНГИБИТОРА TrkA КИНАЗЫ
|
|
WO2016010610A2
(en)
|
2014-07-18 |
2016-01-21 |
Ohio University |
Imidazole and thiazole compositions for modifying biological signaling
|
|
CA2957785C
(en)
|
2014-08-11 |
2023-01-03 |
Angion Biomedica Corporation |
Cytochrome p450 inhibitors and uses thereof
|
|
CN113683564A
(zh)
|
2014-08-28 |
2021-11-23 |
卫材R&D管理有限公司 |
高纯度喹啉衍生物及其生产方法
|
|
UA123084C2
(uk)
|
2014-09-10 |
2021-02-17 |
Глаксосмітклайн Інтеллектьюел Проперті Девелопмент Лімітед |
Сполуки як інгібітори кінази, реаранжованої під час трансфекції (ret)
|
|
UA122213C2
(uk)
|
2014-09-10 |
2020-10-12 |
Глаксосмітклайн Інтеллектьюел Проперті Девелопмент Лімітед |
Сполуки як інгібітори кінази, реаранжованої під час трансфекції (ret)
|
|
US9638690B2
(en)
|
2014-11-07 |
2017-05-02 |
The University Of British Columbia |
Compounds and compositions for use as alkylating agent sensors and methods of use thereof
|
|
WO2016109492A1
(en)
|
2014-12-31 |
2016-07-07 |
Angion Biomedica Corp |
Methods and agents for treating disease
|
|
LT3263106T
(lt)
|
2015-02-25 |
2024-01-10 |
Eisai R&D Management Co., Ltd. |
Chinolino darinių kartumo sumažinimo būdas
|
|
CA2978226C
(en)
|
2015-03-04 |
2025-02-18 |
Eisai R&D Management Co., Ltd. |
COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR TO TREAT CANCER
|
|
CN107801379B
(zh)
|
2015-06-16 |
2021-05-25 |
卫材R&D管理有限公司 |
抗癌剂
|
|
RU2718048C2
(ru)
|
2015-08-20 |
2020-03-30 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Противоопухолевое терапевтическое средство
|
|
WO2018147275A1
(ja)
|
2017-02-08 |
2018-08-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
腫瘍治療用医薬組成物
|
|
RU2019134940A
(ru)
|
2017-05-16 |
2021-06-16 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Лечение гепатоцеллюлярной карциномы
|
|
BR112020015581A2
(pt)
|
2018-01-31 |
2021-02-02 |
Deciphera Pharmaceuticals, Llc |
terapia de combinação para o tratamento de tumores estromais gastrointestinais
|
|
EP3746060A1
(en)
|
2018-01-31 |
2020-12-09 |
Deciphera Pharmaceuticals, LLC |
Combination therapy for the treatment of mastocytosis
|
|
WO2019241089A1
(en)
|
2018-06-12 |
2019-12-19 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
|
KR20220045189A
(ko)
|
2019-08-12 |
2022-04-12 |
데시페라 파마슈티칼스, 엘엘씨. |
위장관 기질 종양을 치료하는 방법
|
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
|
CN118948773A
(zh)
|
2019-12-30 |
2024-11-15 |
德西费拉制药有限责任公司 |
1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物
|
|
SMT202300467T1
(it)
|
2019-12-30 |
2024-01-10 |
Deciphera Pharmaceuticals Llc |
Formulazioni di inibitori di chinasi amorfi e loro procedimenti d’uso
|
|
WO2021167840A1
(en)
|
2020-02-18 |
2021-08-26 |
Vtv Therapeutics Llc |
Sulfoxide and sulfone glucokinase activators and methods of use thereof
|
|
CN116102522A
(zh)
*
|
2021-11-09 |
2023-05-12 |
河南省化工研究所有限责任公司 |
一种阳离子蓝染料中间体的制备方法
|
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|